HMSA

Prometheus Launches Has Introduced New Prometheus Anser Infliximab (Ifx) Monitoring Test
Dec 18, 2012
Prometheus Laboratories, a developer of diagnostic products, has introduced new Prometheus Anser infliximab (IFX) monitoring test. By utilizing the company's proprietary homogenous mobility shift assay (HMSA), the test measures infliximab ...

Tags: Prometheus, IFX, monitoring test, HMSA, IBD